Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
Syntometrine 500 micrograms/5 IU Solution for Injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. The solution is clear, colourless, faintly bluish fluorescent. |
Each 1ml ampoule contains 500 micrograms ergometrine maleate and 5IU oxytocin.
Excipient with known effect:
Sodium chloride 7.000 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ergometrine |
Ergometrine produces sustained tonic uterine contraction via agonist or partial agonist effects at myometrial 5-HT2 receptors and alpha-adrenergic receptors. Both upper and lower uterine segments are stimulated to contract in a tetanic manner. |
|
| Oxytocin |
Oxytocin is a cyclic nonapeptide that is obtained by chemical synthesis. This synthetic form is identical to the natural hormone that is stored in the posterior pituitary and released into the systemic circulation in response to suckling and labour. |
| List of Excipients |
|---|
|
Sodium chloride |
Uncoloured borosilicate glass Type I snap ampoule. Packs of 5 ampoules.
Alliance Pharmaceuticals Limited, Avonbridge House, Bath Road, Chippenham, Wiltshire, SN15 2BB
PL16853/0021
25 June 1998
| Drug | Countries | |
|---|---|---|
| SYNTOMETRINE | Hong Kong, Ireland, Malta, New Zealand, Singapore, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
